Nisa Investment Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Nisa Investment Advisors’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-680	Closed	-$31.6K	–	2884
2023 Q2	$31.6K	Buy	680 +670	+6,700%	+$23.2K	﹤0.01%	1919
2023 Q1	$0	Sell	10 -13	-57%	-$385	﹤0.01%	2787
2022 Q4	$1K	Hold	23	–	–	﹤0.01%	2556
2022 Q3	$1K	Buy	+23	New	+$419	﹤0.01%	2558

Nisa Investment Advisors's DICE Position: Q3 2023 in Review

Nisa Investment Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 680 shares — an estimated $31.6K sold.

Nisa Investment Advisors first reported a position in DICE in Q3 2022 and held it in 4 quarters. The position peaked at $31.6K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Nisa Investment Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Nisa Investment Advisors sold 680 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $31.6K.
Nisa Investment Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Nisa Investment Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $31.6K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.